HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative investigation of the efficacy of triclosan/copolymer/sodium fluoride and stannous fluoride/sodium hexametaphosphate/zinc lactate dentifrices for the control of established supragingival plaque and gingivitis in a six-month clinical study.

AbstractOBJECTIVE:
This double-blind clinical study, conducted at the University of Puerto Rico, San Juan, Puerto Rico, was designed to compare the efficacy of two commercially available dentifrices for the control of supragingival plaque and gingivitis.
METHODS:
Qualifying adult male and female subjects from the San Juan, Puerto Rico area were randomly assigned to one of two treatment groups: 1) a commercially available dentifrice containing 0.3% triclosan, 2.0% PVM/MA copolymer, and 0.243% sodium fluoride (Colgate Total); and 2) a commercially available dentifrice containing 0.454% stannous fluoride, sodium hexametaphosphate, and zinc lactate (Crest Pro-Health). All subjects received an oral soft and hard tissue examination, and were dispensed their assigned dentifrice product, along with a soft-bristled adult toothbrush for home use. Subjects were instructed to brush their teeth for one minute, twice daily (morning and evening), using only the dentifrice provided. Examinations for supragingival plaque and gingivitis, and oral soft and hard tissue assessments were repeated after six weeks, three months, and six months of product use.
RESULTS:
One-hundred and nine (109) subjects complied with the protocol and completed the six-month examinations. At the six-month examination, both treatment groups exhibited statistically significant reductions from baseline with respect to supragingival plaque and gingivitis scores. Relative to the Crest Pro-Health Toothpaste group, the Colgate Total Toothpaste group exhibited statistically significant reductions in supragingival plaque index scores of 18.5%, 20.7%, and 25.8% after six weeks, three months, and six months of product use, respectively. For gingival index scores, statistically significant reductions of 20.5%, 18.9%, and 17.1% were exhibited after six weeks, three months, and six months of product use, respectively.
CONCLUSION:
The results of this double-blind clinical study support the conclusion that a dentifrice containing 0.3% triclosan, 2.0% PVM/MA copolymer, and 0.243% sodium fluoride provides a significant reduction in established supragingival plaque and gingivitis, as compared to a dentifrice containing 0.454% stannous fluoride, sodium hexametaphosphate, and zinc lactate when used over a period of six months.
AuthorsAugusto Elias Boneta, Mauricio Montero Aguilar, Ferdinand Lugo Romeu, Bernal Stewart, William DeVizio, Howard M Proskin
JournalThe Journal of clinical dentistry (J Clin Dent) Vol. 21 Issue 4 Pg. 117-23 ( 2010) ISSN: 0895-8831 [Print] United States
PMID21269041 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Crest Pro-Health Dentifrice
  • Dentifrices
  • Drug Combinations
  • Maleates
  • Phosphates
  • Polyethylenes
  • Tin Fluorides
  • Toothpastes
  • Zinc Compounds
  • hydrated silica gel-based toothpaste
  • Silicic Acid
  • Triclosan
  • Sodium Fluoride
  • poly(methyl vinyl ether-co-maleic anhydride)
  • sodium polymetaphosphate
Topics
  • Adult
  • Aged
  • Analysis of Variance
  • Chi-Square Distribution
  • Dental Plaque (prevention & control)
  • Dental Plaque Index
  • Dentifrices (chemistry, therapeutic use)
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Gingivitis (prevention & control)
  • Humans
  • Male
  • Maleates (therapeutic use)
  • Middle Aged
  • Periodontal Index
  • Phosphates (chemistry, therapeutic use)
  • Polyethylenes (therapeutic use)
  • Silicic Acid (chemistry, therapeutic use)
  • Sodium Fluoride (therapeutic use)
  • Tin Fluorides (chemistry, therapeutic use)
  • Toothpastes (chemistry, therapeutic use)
  • Triclosan (therapeutic use)
  • Young Adult
  • Zinc Compounds (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: